Post Categories
Blog post not found!
CLIA Regulations During the COVID-19 Pandemic
During the ongoing pandemic, all COVID-19-related testing used for the diagnosis, prevention, or treatment of disease, or for a health assessment, must adhere to…
CLIA Regulations During the COVID-19 Pandemic
July 13, 2020
During the ongoing pandemic, all COVID-19-related testing used for the diagnosis, prevention, or treatment of disease, or for a health assessment, must adhere to…
Flortaucipir PET Shows Promise in Alzheimer’s Disease Diagnosis
In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease…
![Close-up of medical professional examining MRI scan](https://www.qps.com/wp-content/uploads/2020/06/Close-up-of-medical-professional-examining-MRI-scan.jpg)
Flortaucipir PET Shows Promise in Alzheimer’s Disease Diagnosis
July 1, 2020
In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease…
Repetitive Negative Thinking Linked to Alzheimer’s Disease
According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease…
![Senior man with thoughtful, worried expression](https://www.qps.com/wp-content/uploads/2020/06/Senior-man-with-thoughtful-worried-expression.jpg)
Repetitive Negative Thinking Linked to Alzheimer’s Disease
June 29, 2020
According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease…
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge,…
![Senior couple on couch looking at book](https://www.qps.com/wp-content/uploads/2020/06/Senior-couple-on-couch-looking-at-book.jpg)
Research Breakthrough: Antibodies for the Quantification of Amyloid Beta Oligomers in Alzheimer’s Disease
June 22, 2020
Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge,…
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many…
![Image for Proteomics Blog Post](https://www.qps.com/wp-content/uploads/2020/06/Image-for-Proteomics-Blog-Post.jpg)
Proteomic Analysis Studies in Alzheimer’s Disease and Cerebral Atherosclerosis Research
June 15, 2020
RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many…
FDA Guidance Documents for COVID-19
COVID-19 was declared a global pandemic on March 11, 2020. As the novel coronavirus continues to dominate headlines and impact communities around the globe,…
![Close-up male doctor using tablet](https://www.qps.com/wp-content/uploads/2020/05/Close-up-male-doctor-using-tablet.jpg)
FDA Guidance Documents for COVID-19
June 10, 2020
COVID-19 was declared a global pandemic on March 11, 2020. As the novel coronavirus continues to dominate headlines and impact communities around the globe,…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…